{"id":"https://openalex.org/W2016521092","doi":"https://doi.org/10.1172/jci71602","title":"Emerging therapies targeting the ubiquitin proteasome system in cancer","display_name":"Emerging therapies targeting the ubiquitin proteasome system in cancer","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2016521092","doi":"https://doi.org/10.1172/jci71602","mag":"2016521092","pmid":"https://pubmed.ncbi.nlm.nih.gov/24382383","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3871250"},"language":"en","primary_location":{"id":"doi:10.1172/jci71602","doi":"https://doi.org/10.1172/jci71602","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci71602","pdf_url":"http://www.jci.org/articles/view/71602/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016521092"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.jci.org/articles/view/71602/files/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002693615","display_name":"Nathaniel M. Weathington","orcid":"https://orcid.org/0000-0002-2937-8432","observed_orcids":["https://orcid.org/0000-0002-2937-8432"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210133905","display_name":"VA Pittsburgh Healthcare System","ror":"https://ror.org/02qm18h86","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210133905","https://openalex.org/I4210147340"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathaniel M. Weathington","raw_affiliation_strings":["Department of Medicine, Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","Medical Specialty Service Line, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Medical Specialty Service Line, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210133905"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030631527","display_name":"Rama K. Mallampalli","orcid":"https://orcid.org/0000-0002-4405-1593","observed_orcids":["https://orcid.org/0000-0002-4405-1593"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210133905","display_name":"VA Pittsburgh Healthcare System","ror":"https://ror.org/02qm18h86","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210133905","https://openalex.org/I4210147340"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rama K. Mallampalli","raw_affiliation_strings":["Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","Department of Medicine, Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","Medical Specialty Service Line, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Department of Medicine, Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Medical Specialty Service Line, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210133905"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5030631527"],"corresponding_institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210133905"],"apc_list":{"value":5200,"currency":"USD","value_usd":5200},"apc_paid":null,"fwci":5.7268,"has_fulltext":true,"cited_by_count":133,"citation_normalized_percentile":{"value":0.97549217,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"124","issue":"1","first_page":"6","last_page":"12"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.9940000176429749},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.7590000033378601},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.8579999804496765},{"id":"https://openalex.org/keywords/antiproliferative-agents","display_name":"antiproliferative agents","score":0.9409999847412109},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6899999976158142},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.8813274502754211},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.6429195404052734},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5569227933883667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48090386390686035},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.47054487466812134},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.46353960037231445},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4563092291355133},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42074882984161377},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34331464767456055},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.33119434118270874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3236646056175232},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3134115934371948},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20620134472846985},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13594287633895874},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0721530020236969},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07122820615768433}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044767","descriptor_name":"Ubiquitin-Protein Ligases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D044767","descriptor_name":"Ubiquitin-Protein Ligases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054875","descriptor_name":"Ubiquitination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1172/jci71602","doi":"https://doi.org/10.1172/jci71602","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci71602","pdf_url":"http://www.jci.org/articles/view/71602/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3244713","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3871250","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24382383","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24382383","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical investigation","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3871250","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3871250/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Invest","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1172/jci71602","doi":"https://doi.org/10.1172/jci71602","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci71602","pdf_url":"http://www.jci.org/articles/view/71602/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1529291882","display_name":"Regulation of the interferon lamda receptor by influenza","funder_award_id":"R01HL081784","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5075189614","display_name":"Stabilizing mitochondria in sepsis","funder_award_id":"R01HL098174","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5520316217","display_name":null,"funder_award_id":"NIH-R01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5728561071","display_name":null,"funder_award_id":"HL114453","funder_id":"https://openalex.org/F4320310174","funder_display_name":"University of Pittsburgh"},{"id":"https://openalex.org/G7209639321","display_name":null,"funder_award_id":"I01 BX002200","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G7562710908","display_name":"A New Genus of Ubiquitin-Based Anti-inflammatories for COPD","funder_award_id":"UH2HL123502","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G8039370953","display_name":"Immunosuppression in Acute Lung Injury","funder_award_id":"P01HL114453","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000856219","display_name":"Sepsis-Associated Immune Suppression and F-box Proteins","funder_award_id":"R01HL097376","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000888065","display_name":"E3 Ligase-Mediated Immunosuppression in Acute Lung Injury","funder_award_id":"R01HL096376","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320309037","display_name":"Office of Research and Development","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320310174","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016521092.pdf","grobid_xml":"https://content.openalex.org/works/W2016521092.grobid-xml"},"referenced_works_count":72,"referenced_works":["https://openalex.org/W1597238753","https://openalex.org/W1708445842","https://openalex.org/W1965604161","https://openalex.org/W1966942554","https://openalex.org/W1974512281","https://openalex.org/W1981701450","https://openalex.org/W1982791431","https://openalex.org/W1982819726","https://openalex.org/W1985299376","https://openalex.org/W1987583882","https://openalex.org/W1993148588","https://openalex.org/W1994344724","https://openalex.org/W1997952190","https://openalex.org/W2012296420","https://openalex.org/W2021115672","https://openalex.org/W2022568271","https://openalex.org/W2025656486","https://openalex.org/W2029454644","https://openalex.org/W2029597892","https://openalex.org/W2038852478","https://openalex.org/W2040478292","https://openalex.org/W2044596049","https://openalex.org/W2048915877","https://openalex.org/W2051458654","https://openalex.org/W2052735334","https://openalex.org/W2052894358","https://openalex.org/W2056181814","https://openalex.org/W2061156149","https://openalex.org/W2065629914","https://openalex.org/W2066713758","https://openalex.org/W2066800926","https://openalex.org/W2068010171","https://openalex.org/W2068931555","https://openalex.org/W2070205812","https://openalex.org/W2072310367","https://openalex.org/W2076194625","https://openalex.org/W2082015682","https://openalex.org/W2082273145","https://openalex.org/W2082863510","https://openalex.org/W2083365324","https://openalex.org/W2088765731","https://openalex.org/W2089451770","https://openalex.org/W2090310344","https://openalex.org/W2096207943","https://openalex.org/W2097933346","https://openalex.org/W2107252423","https://openalex.org/W2108235071","https://openalex.org/W2108492672","https://openalex.org/W2109295630","https://openalex.org/W2111796766","https://openalex.org/W2118225942","https://openalex.org/W2118820477","https://openalex.org/W2119182570","https://openalex.org/W2127120815","https://openalex.org/W2134404356","https://openalex.org/W2135072453","https://openalex.org/W2135527052","https://openalex.org/W2142492664","https://openalex.org/W2146204355","https://openalex.org/W2147644408","https://openalex.org/W2153088263","https://openalex.org/W2155561150","https://openalex.org/W2163495162","https://openalex.org/W2164753815","https://openalex.org/W2168980644","https://openalex.org/W2169045918","https://openalex.org/W2171062007","https://openalex.org/W2526922410","https://openalex.org/W2614257677","https://openalex.org/W3112912921","https://openalex.org/W3195431600","https://openalex.org/W4252175385"],"related_works":["https://openalex.org/W96728687","https://openalex.org/W2078699393","https://openalex.org/W3103268846","https://openalex.org/W2010033523","https://openalex.org/W2921123848","https://openalex.org/W3177376878","https://openalex.org/W8832395","https://openalex.org/W1977479320","https://openalex.org/W7167691526","https://openalex.org/W4414822851"],"abstract_inverted_index":{"The":[0],"ubiquitin":[1],"proteasome":[2,30,56],"system":[3],"(UPS)":[4],"is":[5,44],"an":[6],"essential":[7],"metabolic":[8],"constituent":[9],"of":[10,28,38,62,80,92],"cellular":[11,16,25],"physiology":[12],"that":[13],"tightly":[14],"regulates":[15],"protein":[17],"concentrations":[18],"with":[19],"specificity":[20],"and":[21,41,89,94],"precision":[22],"to":[23],"optimize":[24],"function.":[26],"Inhibition":[27],"the":[29,36,55,63,78,90],"has":[31],"proven":[32],"very":[33],"effective":[34],"in":[35,49,66],"treatment":[37],"multiple":[39],"myeloma,":[40],"this":[42,74],"approach":[43],"being":[45],"tested":[46],"for":[47,87,97],"utility":[48],"other":[50],"malignancies.":[51],"New":[52],"pharmaceuticals":[53],"targeting":[54],"itself":[57],"or":[58,70],"specific":[59],"proximal":[60],"pathways":[61],"UPS":[64],"are":[65],"development":[67,96],"as":[68,85],"antiproliferatives":[69],"immunomodulatory":[71],"agents.":[72],"In":[73],"article,":[75],"we":[76],"discuss":[77],"biology":[79],"UPS-targeting":[81],"drugs,":[82],"their":[83],"use":[84],"therapy":[86],"neoplasia,":[88],"state":[91],"clinical":[93],"preclinical":[95],"emerging":[98],"therapeutics.":[99]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016521092","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":22},{"year":2014,"cited_by_count":8}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
